Year 2013

Food Culture Clash: EU, US Conflicting Concepts For GIs; Both Covet Asian Market

Geographical indications were born in Europe and still remain a widely used means to protect products from a particular region, with particular characteristics. The European Union has been a strong advocate of GIs in international negotiations, while their efforts have been countered by countries such as the United States which favour a trademark system. Now both sides are trying to impose their views through bilateral trade agreements, including with each other, according to speakers at a recent conference. And now a US trade association for generic names is raising concerns in Europe.

World Health Assembly: IP Considerations Play Key Role In Final Outcomes

Wrapping up one day early, the 66th World Health Assembly adopted a range of public health resolutions and decisions, some with key intellectual property implications, including a decision to convene a technical meeting on new public health R&D projects, a compromise on advancing the poor quality medicines mechanism, and resolutions on both neglected tropical diseases and noncommunicable diseases. Importantly, the novel coronavirus situation drew attention to WHO’s progress in pandemic influenza preparedness.

World Health Assembly: As Members Approve Health R&D Decisions, US Says Time To “Put Our Money Where Our Mouth Is”

Heading into the 66th World Health Assembly, the prospect of a global treaty to address the health needs of developing countries seemed unlikely and years away at best. In a surprising turn in this highly political conversation, the US challenged member states to prove that it could work. That process will start sooner rather than later as members gavelled the resolution and agreed to convene a meeting on health R&D demonstration projects in the next few months.

World Health Assembly: Pandemic Flu Framework Clears Committee

Member states gathered at the annual World Health Assembly took note of a report on its pandemic influenza preparedness (PIP) framework amid encouragement by developed countries that standard agreements for transferring materials be completed, and reminders from some developing countries of the need for fair access and benefit-sharing of the resulting treatments.